Insights > Uncategorized
Uncategorized
Bionovis’s Acquisition of technologies to Produce Trastuzumab
8 de julho de 2020
Cescon, Barrieu, Flesch & Barreto and Demarest advised on the deal
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.
Áreas Relacionadas